Lung

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(CCTG) BR.31A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 In Completely Resected Non-Small Cell Lung CancerJuergens, Dr RosalynOpen to recruitmentNCT02273375
(CCTG) IND.227A Phase II Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural MesotheliomaGoffin, Dr JohnOpen to recruitmentNCT02784171
(HHS) LINNEARRE IPhase I study of neo-adjuvant stereotactic body radiotherapy (SBRT) in operable patients with borderline resectable locally advanced non-small cell lung cancer (NSCLC)Tsakiridis, Dr TheosOpen to recruitmentNCT02433574
(Turnstone) Ad/MG1-MAGEA3-001 / SandpiperA Phase 1/2, Multicenter, Open-Label Trial of MG1 Maraba Expressing MAGEA3 (MG1-MAGEA3), with Adenovirus Vaccine Expressing MAGE-A3 (Ad-MAGEA3), in Combination with Pembrolizumab in Patients with Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC)Juergens, Dr RosalynOpen to recruitmentNCT02879760
OCOG-2013-LUSTREA Randomized Trial of Medically-Inoperable Stage I Non-Small Cell Lung Cancer Patients Comparing Stereotactic Body Radiotherapy Versus Conventional Radiotherapy (LUSTRE)Swaminath, Dr AnandOpen to recruitmentNCT01968941
OCOG-2014-ALMERAA Phase II Study to Investigate a Combination of Metformin With Chemo-Radiotherapy in Patients With Locally Advanced Non-Small Cell Lung CancerWright, Dr JimOpen to recruitmentNCT02115464
Download PDF